NP Thyroid Medication Recall

Thyroid medication recall

NORTH AMERICA – June 1, 2020 – According to an online news report provided by the news website AJC.com, Acella Pharmaceuticals is recalling several lots of their thyroid drug due to severe adverse effects. The Alpharetta-based company received two adverse effects reports alleging patients prescribed the medication suffered adverse reactions, according to the FDA. After receiving these adverse reports from the FDA, Acella Pharmaceuticals tested their NP Thyroid drug and discovered some lots were “super potent.” They discovered the some of the medications had up to 115% of the hormone liothyronine that is listed on the labeled. Liothyronine is a hormone that treats under-active thyroid conditions.

According to the FDA, patients who consume the super potent NP Thyroid tablets may suffer serious side effects such as muscle weakness, chest pain, fatigue, a rapid heartbeat, or other heart-related episodes. More serious side effects include impaired fetal development or miscarriages in women who were pregnant at the time they took the super potent NP Thyroid medication. Acella Pharmaceuticals’ NP Thyroid drug is distributed throughout the United States and comes in 30 mg, 60 mg, and 90 mg tablets. The recalled tablets come in 100-count bottles, and they have an expiration date of July, August, November, or December of 2020. The Food and Drug Administration website provides a list of the lots affected and can be found here. Patients may also email at recall@acellapharma.com or contact Acella Pharmaceuticals at 1-800-541-4802 for assistance.

Acella Pharmaceuticals is reporting the recall to its wholesale distributors in order to stop distributing the medications. The FDA recommends that patients currently taking NP Thyroid should not discontinue taking the medications without talking to their prescribing physician for guidance and a new prescription.